{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:37:33Z","timestamp":1789699053268,"version":"4.0.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/mnm.0b013e328330adc5","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T03:20:14Z","timestamp":1259724014000},"page":"39-45","source":"Crossref","is-referenced-by-count":128,"title":["18F-choline PET\/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer"],"prefix":"10.1097","volume":"31","author":[{"given":"Orazio","family":"Schillaci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tavolozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Cicci\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana R.","family":"Caracciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Danieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Orlacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210212","first-page":"245","article-title":"PET\/CT for treatment planning in prostate cancer","volume":"53","author":"Picchio","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R2-7-20210212","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00120-006-1212-6","article-title":"PET and PET\/CT in relapsing prostate carcinoma","volume":"45","author":"Reske","year":"2006","journal-title":"Urologe A"},{"key":"R3-7-20210212","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11547-008-0263-8","article-title":"Role of whole-body (18)F-choline PET\/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer","volume":"113","author":"Pelosi","year":"2008","journal-title":"Radiol Med"},{"key":"R4-7-20210212","first-page":"180","article-title":"Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglucose (FDG): applications, limitations and potential","volume":"10","author":"Mercer","year":"2007","journal-title":"J Pharm Pharm Sci"},{"key":"R5-7-20210212","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","article-title":"The detection rate of [(11)C]choline-PET\/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer","volume":"35","author":"Krause","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-7-20210212","first-page":"95","article-title":"PET\/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer","volume":"28","author":"Garcia","year":"2009","journal-title":"Rev Esp Med Nucl"},{"key":"R7-7-20210212","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.semnuclmed.2005.09.002","article-title":"The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline and 18F-fluoride in bone imaging with emphasis on prostate and breast","volume":"36","author":"Langsteger","year":"2006","journal-title":"Semin Nucl Med"},{"key":"R8-7-20210212","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1148\/rg.245035725","article-title":"PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake","volume":"24","author":"Kostakoglu","year":"2004","journal-title":"Radiographics"},{"key":"R9-7-20210212","first-page":"156","article-title":"PET\/CT imaging artefacts","volume":"33","author":"Sureshbabu","year":"2005","journal-title":"J Nucl Med Technol"},{"key":"R10-7-20210212","first-page":"172","article-title":"Comparison of 11C-choline and 18F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.","volume":"167-","author":"Pieterman","year":"43","journal-title":"J Nuc Med"},{"key":"R11-7-20210212","first-page":"428","article-title":"Cancer imaging with fluorine-18-labeled choline derivatives.","volume":"420-","author":"Kwee","year":"37","journal-title":"Semin Nucl Med"},{"key":"R12-7-20210212","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00029330-200604020-00004","article-title":"The role of 11C-choline positron emission tomography-computed tomography and videomediastinoscopy in the evaluation of diseases of middle mediastinum","volume":"119","author":"Liu","year":"2006","journal-title":"Chin Med J"},{"key":"R13-7-20210212","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00259-003-1337-4","article-title":"18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET","volume":"31","author":"Wyss","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-7-20210212","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s002590100655","article-title":"Carbon-11 choline or FDG-PET for staging of oesophageal cancer?","volume":"28","author":"Jager","year":"2001","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-7-20210212","first-page":"235","article-title":"Pitfalls in PET\/CT interpretation","volume":"3","author":"Cook","year":"2007","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R16-7-20210212","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s002590100620","article-title":"Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging","volume":"28","author":"Ohtani","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R17-7-20210212","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00330-008-1079-6","article-title":"New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma","volume":"18","author":"Yue","year":"2008","journal-title":"Eur Radiol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0b013e328330adc5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:07:56Z","timestamp":1786039676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-201001000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328330adc5","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}